Vivo Capital, LLC: 13F holdings
CIK 16747122026Q2
| Positions | 47 |
|---|
| Reported value | $1.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 47 (+1 vs prior quarter) |
|---|
| Reported value | $1.1bn (-9.0%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| TRVI Trevi Therapeutics Inc | 5,094,668 | $95.0m | 8.7% |
| PRAX Praxis Precision Medicines | 271,116 | $90.8m | 8.3% |
| ERAS Erasca Inc | 4,127,412 | $75.6m | 6.9% |
| AVBP Arrivent BioPharma Inc | 1,682,097 | $58.4m | 5.3% |
| ABVX Abivax SA - ADR | 414,899 | $55.3m | 5.0% |
| TNGX Tango Therapeutics Inc | 1,379,769 | $43.1m | 3.9% |
| CRVS Corvus Pharmaceuticals Inc | 2,805,816 | $41.9m | 3.8% |
| DRUG Bright Minds Biosciences Inc | 557,172 | $39.1m | 3.6% |
| Sinovac Biotech Ltd. | 5,903,000 | $38.2m | 3.5% |
| Tenax Therapeutics Inc | 2,500,000 | $36.4m | 3.3% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1674712")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples